Added value of 3D echocardiography in the diagnosis and prognostication of patients with right ventricular dysfunction

Michael Randazzo; Francesco Maffessanti; Alekhya Kotta; Julia Grapsa; Roberto M Lang; Karima Addetia

doi:10.3389/fcvm.2023.1263864

Added value of 3D echocardiography in the diagnosis and prognostication of patients with right ventricular dysfunction

Front Cardiovasc Med. 2023 Dec 21:10:1263864. doi: 10.3389/fcvm.2023.1263864. eCollection 2023.

Authors

Michael Randazzo¹, Francesco Maffessanti², Alekhya Kotta³, Julia Grapsa⁴, Roberto M Lang¹, Karima Addetia¹

Affiliations

¹ Department of Medicine, Section of Cardiology, University of Chicago Heart and Vascular Center, Chicago, IL, United States.
² Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy.
³ Department of Internal Medicine, Baylor College of Medicine, Houston, TX, United States.
⁴ Department of Cardiology, Guys and St Thomas NHS Trust, London, United Kingdom.

Abstract

Recent inroads into percutaneous-based options for the treatment of tricuspid valve disease has brought to light how little we know about the behavior of the right ventricle in both health and disease and how incomplete our assessment of right ventricular (RV) physiology and function is using current non-invasive technology, in particular echocardiography. The purpose of this review is to provide an overview of what three-dimensional echocardiography (3DE) can offer currently to enhance RV evaluation and what the future may hold if we continue to improve the 3D evaluation of the right heart.

Keywords: 3D echocardiography; echocardiography; prognosis; right ventricle; tricuspid valve.

Publication types

Review

Grants and funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.